Inherited Risk | Targeted Screening
Genetic Risk Screening
Genetic Risk Screening
When a particular inherited condition is the concern, targeted testing is usually more useful than broad genetic exploration. Genetic Risk Screening at Yoyime Wellness Clinic in Dubai focuses on a defined hereditary risk identified through personal history, family history or an existing clinical concern. Our clinician determines whether a specific gene or multigene panel is appropriate and discusses what a positive, negative or uncertain result may mean. Findings may influence condition specific surveillance, prevention, family counselling or specialist referral where established clinical guidance supports action.
Benefits of Genetic Risk Screening
Targets Specific Risks
Clarifies Family Concerns
Guides Relevant Screening
Recommended for Patients With
Strong Family Disease History
Known Familial Genetic Variant
Specific Hereditary Risk Concerns
Step-By-Step Procedure - Genetic Risk Screening
Risk Question
Define the specific inherited disease or family pattern requiring investigation.
Family History
Affected relatives, age at diagnosis and relevant familial findings are documented.
Existing Results
Any previous genetic reports from the patient or relatives are reviewed.
Test Selection
The most appropriate single gene or targeted multigene panel is selected.
Sample Collection
The required blood or saliva sample is collected for genetic analysis.
Variant Analysis
The laboratory evaluates variants relevant to the specific clinical question.
Risk Interpretation
Our clinician considers findings alongside personal and family risk information.
Follow Up Planning
Appropriate surveillance, specialist referral or family counselling is discussed where indicated.
Have questions about Genetic Risk Screening?
Message our team on WhatsApp for personalised guidance before you book.
- Investigate selected inherited disease risks using targeted clinically appropriate genetic testing.
- Focus testing around personal history, family patterns and specific clinical questions.
Frequently Asked Questions
Genetic Risk Screening
Targeted genetic screening may be appropriate when a particular hereditary condition runs in your family, a relative has a known pathogenic variant or your personal and family history suggests a specific inherited risk.
Yoyime's Genetic Risk Screening in Dubai uses targeted genetic testing to investigate a defined inherited health concern rather than providing a broad genomic overview.
Depending on individual history, genetic testing may be considered for hereditary conditions such as selected cancer syndromes, familial hypercholesterolaemia and other recognised inherited disorders.
Genetic Risk Screening starts with one defined risk question. Comprehensive Genetic Health Screening has a broader scope and may assess multiple selected hereditary health areas within one test.
Yes. If a clinically significant familial variant has already been identified, targeted testing for that specific change may be appropriate.
Yes. Some inherited conditions can involve several genes, so a focused multigene panel may be more appropriate than testing one gene alone.
No. For many conditions, age, lifestyle, environment and other clinical factors also contribute to overall risk. Genetic information is one part of the wider assessment.
It is a genetic change for which available evidence is insufficient to determine whether it causes disease. Such findings should not be treated as confirmed disease causing variants.
Yes. Because inherited variants can be shared among relatives, significant findings may lead to genetic counselling or targeted testing for appropriate family members.
Cost depends on the gene or targeted panel required. At Yoyime, our team explains the selected test, its scope and associated costs before proceeding.
Yes. When a particular inherited condition or family risk is known, targeted genetic testing can assess relevant genes or a known familial variant. Our clinician interprets the result within your personal and family history and recommends appropriate counselling, surveillance or specialist follow-up where indicated.
